High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality - PASS-CRB-APHP-SU - Centre de Ressources Biologiques APHP-SU
Article Dans Une Revue European Heart Journal - Cardiovascular Pharmacotherapy Année : 2020

High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality

Résumé

Full secondary prevention medication regimen is often under-prescribed after acute myocardial infarction.
Fichier principal
Vignette du fichier
pvz049.pdf (370.49 Ko) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03028620 , version 1 (30-11-2020)

Identifiants

Citer

Nicolas Danchin, Tabassome Simon. High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality. European Heart Journal - Cardiovascular Pharmacotherapy, 2020, 6 (4), pp.328 - 330. ⟨10.1093/ehjcvp/pvz049⟩. ⟨hal-03028620⟩
182 Consultations
52 Téléchargements

Altmetric

Partager

More